Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.
about
Nasal saline for allergic rhinitisLeukotriene receptor antagonists for rhinosinusitisLeukotriene receptor antagonists for rhinosinusitisNasal saline for allergic rhinitisUnited airway disease: current perspectivesAsthma phenotypes: the intriguing selective intervention with MontelukastCysteinyl leukotrienes: multi-functional mediators in allergic rhinitisAntileukotrienes in upper airway inflammatory diseasesSublingual immunotherapy: World Allergy Organization position paper 2013 update.Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis.Perennial rhinitis.Rhinitis in the geriatric population.Treatment of congestion in upper respiratory diseases.A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitisHay fever in adolescents and adults.Clinical practice guideline: Allergic rhinitis.Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluatedManagement of persistent allergic rhinitis: evidence-based treatment with levocetirizineRhinitis in children less than 6 years of age: current knowledge and challenges.How an online survey on the treatment of allergic rhinitis and its impact on asthma (ARIA) detected specialty-specific knowledge-gaps.Optimal management of allergic rhinitis.Emerging anti-inflammatory agents for allergic rhinitis.Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).Montelukast in allergic rhinitis: a systematic review and meta-analysis.The impact of comorbid atopic disease on asthma: clinical expression and treatment.Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.The effect of combined medical treatment on quality of life in persistent allergic rhinitisThe assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamberRole of antioxidants on the clinical outcome of patients with perennial allergic rhinitis.Therapeutic management of allergic diseases.Allergic rhinitis in women.Investigational drugs for allergic rhinitis.The link between allergic rhinitis and asthma: the united airways disease.Emerging sublingual immunotherapy drugs.Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology.Pediatric allergic rhinitis and asthma: can the march be halted?Balancing efficacy against safety in sublingual immunotherapy with inhalant allergens: what is the best approach?Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond.Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.
P2860
Q24198957-2C678BD2-6F69-4FF5-9EB7-A5316E764E54Q24203622-19CC59DE-FEB0-4114-8FB5-D15ABE670027Q24240787-BC6C1617-367F-4986-8013-A893CA01FCE7Q26471842-77B3C9D4-5555-4815-922E-062BBBE09BB7Q26743436-F1C92F92-40CD-41E9-B63F-988F3967C9E9Q28071735-AC5194CC-A529-4A4F-81DF-B8236463CD60Q28219122-9D985E60-7172-4A68-A165-BCA6BB7299D9Q28267571-71C1FE3F-562E-4E44-8C38-1498B123EE58Q30440195-9299568E-4E0C-41DF-813B-9E32A5C86858Q30443913-9364CC3C-51CC-41E5-939B-30A4ABCDC3C4Q30479621-027B63A8-FBFF-4CEE-B672-7FEA21447D54Q30481057-4CE38E90-8316-4DD8-9472-B087F70DCDE0Q30481520-DEB7CEC8-F258-4434-8C3C-A540660470C9Q33914193-8984FA2A-9838-4D99-9EAD-BC26940141E6Q33949990-0FE3233C-0CDE-452C-B706-7136DBBCC401Q34460983-E2A8FC6C-66D0-424B-B6B1-7FFCE1B5D230Q34620179-6E1B944A-8387-4A81-BD97-B7ABC2B3522EQ35166733-804D1FA0-EF3A-485F-B0DC-7FA366C93F1CQ35502538-7722721B-E994-42BC-8573-53EEC044EF80Q35622364-6FEB3361-F188-477B-AC50-5C547EEE33ABQ35888881-196DA116-D8F2-49E0-961F-0402096493C1Q36302823-8311A09B-2861-4EF1-AB3E-AA172AB0C7D3Q36570549-32BD8E9E-FE65-46CA-9E92-8B0FF3BF7F39Q36609797-5F2E77E9-1FC0-4607-86F8-349196D2B15BQ36799761-D4AEF9B5-168C-49E6-BFB2-3E5EF2CBF367Q36966123-624F7863-1882-4FD7-965C-B17AF8B2ECBCQ37083339-1D867DBF-8B21-46AD-9CFB-25F1F05A47D1Q37166886-584BB10B-6E53-408D-B722-372587D4C365Q37230372-EE85592E-F00C-4842-A755-A7A75490F4BEQ37550543-3C50E3CF-2448-4FD0-9E71-CD44737F9DD9Q37608446-5EA7F191-A2BD-4DDF-9384-3EA31300AA96Q37650382-626EFA5E-E5F1-4233-A62D-62E61A2C1D8CQ37742100-85179C9E-84CC-4FB4-B3BC-AED7C4683EAEQ37801372-B09AFE60-8C44-46DD-8FBB-AC2EB6C847E7Q38120057-077C8E1F-9C06-4FA6-A68D-3918A43AD281Q38129435-D3D59076-F8C9-4D04-845F-BB99649FCEF3Q38129766-EBCCB2D9-584F-4F85-A8E5-52371C5D8198Q38149941-8B4E7B9C-27E4-4F6D-B11C-E40E107F1EC9Q38205858-222C2935-EEA1-412B-8872-AACD53D7E635Q38206795-9837A065-BE0A-4190-AD40-E74224C10BC0
P2860
Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Leukotriene receptor antagonis ...... atic review and meta-analysis.
@ast
Leukotriene receptor antagonis ...... atic review and meta-analysis.
@en
type
label
Leukotriene receptor antagonis ...... atic review and meta-analysis.
@ast
Leukotriene receptor antagonis ...... atic review and meta-analysis.
@en
prefLabel
Leukotriene receptor antagonis ...... atic review and meta-analysis.
@ast
Leukotriene receptor antagonis ...... atic review and meta-analysis.
@en
P1476
Leukotriene receptor antagonis ...... matic review and meta-analysis
@en
P2093
Andrew M Wilson
Krishnan Parameswaran
P304
P356
10.1016/J.AMJMED.2003.10.030
P407
P577
2004-03-01T00:00:00Z